People · Operator
Named in public records as an officer, director or promoter · active 2010–2016 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nitinol Devices & Components, Inc. | — | Other Health Care | Series C | $55.7M | $1.3B | 2016 |
| CoreLab Partners, Inc. | — | Biotechnology | Series A | $15.7M | $315.0M | 2010 |
Richard A. Charpie at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard A. Charpie on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Eugene D. Hill | 1 | 5 |
| Herbert H. Hooper | 1 | 3 |
| Denis J. Manginelli | 1 | 2 |
| Dean W. Schauer | 1 | 1 |
| Thomas W. Duerig | 1 | 1 |
| John W. Fruth | 1 | 1 |
| Michael Woehler | 1 | 1 |
| Andrew T. Jay | 1 | 1 |
| Suzanne E. MacCormack | 1 | 1 |
| Dieter W. Stoeckel | 1 | 1 |
| Jared Bartok | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.